Sorry, this article is only available in French.
Le médecin et chercheur japonais, Shinya Yamanaka, récompensé par le Prix Nobel le 8 octobre dernier pour ses travaux sur les cellules IPS (Induced Pluripotent Stem cells), a visité, ce jour, le laboratoire I-Stem (Institut des cellules souches pour le traitement et l'étude des maladies monogéniques).
A team of researchers from Strasbourg, directed by Luc Dupuis (Inserm unit 692 “molecular signalling and neurodegeneration”), have recently discovered the origin of spasms - a disabling symptom of amyotrophic lateral sclerosis.
Nathalie Vergnolle, director of research at Inserm, and her team at the Centre for Physiopathology at Toulouse Purpan (CPTP Inserm / Université Toulouse III – Paul Sabatier /CNRS), with Philippe Langella director of research at INRA and his team at the Institut Micalis[1], in collaboration with the Institut Pasteur, have recently succeeded in producing “beneficial bacteria” capable of protecting the body against intestinal inflammation.
The researcher Capucine Picard, working with the team from Inserm unit 980 "Human genetics and infections diseases" has succeeded in identifying the part played by the HOIL1 gene in cases of paradoxal association of an immune deficiency with a chronic autoinflammatory deficiency and a muscular deficiency in 3 children from 2 different families.
Researchers from Inserm and CNRS from the Institute for genetics and molecular and cellular biology (IGBMC) and from the Research Institute at the Strasbourg school of biotechnology (Irebs) have focussed their efforts on PARG, currently thought to be a promising new therapeutic target in the treatment of cancer.
